• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

    0.4406 -0.0472 (-9.68%)
    Streaming Delayed Price Updated: 3:14 PM EDT, Jun 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Medicus Pharma Ltd. - Common Stock

    < Previous 1 2 3 4 5 Next >
    News headline image
    Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
    Via ACCESS Newswire
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
    Via Chartmill
    Disrupting a $6 Billion Skin Cancer Market: The Small-Cap Biotech (MDCX) Advancing a Non-Surgical Patch
    Via AB Newswire
    News headline image
    Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers
    From Medicus Pharma Ltd.
    Via GlobeNewswire
    News headline image
    Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
    SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health impact, unmet medical need, access,... 
    From Medicus Pharma
    Via GlobeNewswire
    News headline image
    Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
    Via ACCESS Newswire
    Medicus Pharma Ltd. (NASDAQ: MDCX) and the Patch That Could End Repetitive Cancer Surgeries
    Via AB Newswire
    Emerging Biotech Stars Poised for Multi-Billion-Dollar Breakthroughs (MDCX, ACTU, LTRN, TNXP)
    Via AB Newswire
    News headline image
    Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome
    Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC)... 
    From Medicus Pharma
    Via GlobeNewswire
    4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA)
    Via AB Newswire
    News headline image
    Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
    Via ACCESS Newswire
    4 Diagnostic Stocks Targeting 25%+ Annual Growth in a $20B Market (MDCX, ILMN, EXAS, GH)
    Via AB Newswire
    News headline image
    Three Biotech Companies Redefining Value Creation Through Dual Strategies
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
    Via ACCESS Newswire
    Medicus Pharma (Nasdaq: MDCX) Nears Surgery-Free Breakthrough in Oncology
    Via AB Newswire
    News headline image
    Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
    Via ACCESS Newswire
    Medicus Pharma (Nasdaq: MDCX) Bringing Scar-Free, Outpatient Treatment to an $8 Billion Cancer Market
    Via AB Newswire
    News headline image
    Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
    Via ACCESS Newswire
    News headline image
    Biotech Stocks Positioned to Transform Treatment With Next-Gen Therapeutics
    Comtex News Network, Inc. is a content specialist offering actionable news distribution, global syndication, and traffic for your content 
    Via News Direct
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million. 
    Via Benzinga
    Biotech Stocks Positioned to Transform Treatment With Next-Gen Therapeutics (MDCX, PRTC, RANI, INO)
    Via AB Newswire
    News headline image
    Stonegate Capital Partners Initiates Coverage on Medicus Pharma Ltd. (MDCX)
    Dallas, Texas--(Newsfile Corp. - September 24, 2025) - Medicus Pharma... 
    Via Newsfile
    News headline image
    Medicus Pharma Ltd. To Present at Brookline Capital Markets
    Via ACCESS Newswire
    News headline image
    4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR)
    Comtex News Network, Inc. is a content specialist offering actionable news distribution, global syndication, and traffic for your content 
    Via News Direct
    News headline image
    Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing
    Via ACCESS Newswire
    4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR)
    Via AB Newswire
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.